Atri Plus Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Na hyaluronate

Indications/Uses

Symptomatic pain relief in patients w/ OA or joint degenerative disease causing synovial fluid dysfunction.

Click to view Atri Plus detailed prescribing information

Dosage/Direction for Use

Inj 1 pre-filled syringe once wkly for 3 consecutive wk.

Click to view Atri Plus detailed prescribing information

Contraindications

History of hypersensitivity. Not to be used if there is skin infection or disease in the area to be injected; if knee joint to be injected is in a state of severe infection or inflammation.

Click to view Atri Plus detailed prescribing information

Special Precautions

Not for ophth use. Avoid concomitant use w/ other IA treatment. Pregnancy & lactation. Childn. Elderly.

Click to view Atri Plus detailed prescribing information

Adverse Reactions

Joint discomfort, transient joint pain & inflammation.

Click to view Atri Plus detailed prescribing information

Drug Interactions

Concomitant use w/ quaternary ammonium salts ie, benzalkonium Cl may cause precipitation of hyaluronic acid.

Click to view Atri Plus detailed prescribing information

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of the musculo-skeletal system.

Regulatory Classification

Presentation/Packing

Form

Atri Plus inj 1%

Packing/Price

2 mL x 3 × 1's

Atri Plus

sodium hyaluronate

Manufacturer:

Interbat

Marketer:

Interbat